skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 3,890  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
Material Type:
Article
Add to My Research

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

Journal of clinical oncology, 2020-04, Vol.38 (12), p.1346-1366 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.19.02309 ;PMID: 31928404

Full text available

2
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
Material Type:
Article
Add to My Research

Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

JNCI : Journal of the National Cancer Institute, 2006-02, Vol.98 (4), p.262-272 [Peer Reviewed Journal]

2006 INIST-CNRS ;Copyright Oxford University Press(England) Feb 15, 2006 ;ISSN: 0027-8874 ;ISSN: 1460-2105 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djj052 ;PMID: 16478745 ;CODEN: JNCIEQ

Full text available

3
Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831
Material Type:
Article
Add to My Research

Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831

Journal of clinical oncology, 2014-11, Vol.32 (33), p.3744-3752 [Peer Reviewed Journal]

2014 by American Society of Clinical Oncology. ;2014 by American Society of Clinical Oncology 2014 ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2014.55.5730 ;PMID: 25332249

Full text available

4
The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer
Material Type:
Article
Add to My Research

The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer

JNCI : Journal of the National Cancer Institute, 2016-08, Vol.108 (8) [Peer Reviewed Journal]

The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. ;The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. 2016 ;ISSN: 1460-2105 ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djw029 ;PMID: 27107051

Full text available

5
Molecular phenotypes of DCIS predict overall and invasive recurrence
Material Type:
Article
Add to My Research

Molecular phenotypes of DCIS predict overall and invasive recurrence

Annals of oncology, 2015-05, Vol.26 (5), p.1019-1025 [Peer Reviewed Journal]

2015 European Society for Medical Oncology ;The Author 2015. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdv062 ;PMID: 25678586

Full text available

6
Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients
Material Type:
Article
Add to My Research

Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients

Scientific reports, 2018-08, Vol.8 (1), p.12974-10, Article 12974 [Peer Reviewed Journal]

2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-018-31108-y ;PMID: 30154547

Full text available

7
Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer
Material Type:
Article
Add to My Research

Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer

JNCI : Journal of the National Cancer Institute, 2017-01, Vol.109 (1), p.djw192 [Peer Reviewed Journal]

The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2016 ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djw192 ;PMID: 27737921

Full text available

8
Acetate Dependence of Tumors
Material Type:
Article
Add to My Research

Acetate Dependence of Tumors

Cell, 2014-12, Vol.159 (7), p.1591-1602 [Peer Reviewed Journal]

2014 Elsevier Inc. ;Copyright © 2014 Elsevier Inc. All rights reserved. ;2014 Elsevier Inc. All rights reserved. 2014 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2014.11.020 ;PMID: 25525877

Full text available

9
Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial
Material Type:
Article
Add to My Research

Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial

The lancet oncology, 2014-06, Vol.15 (7), p.689-699 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 2014 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(14)70178-0 ;PMID: 24793816 ;CODEN: LANCAO

Full text available

10
Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study
Material Type:
Article
Add to My Research

Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study

Journal of clinical oncology, 2017-01, Vol.35 (2), p.141-148 [Peer Reviewed Journal]

2016 by American Society of Clinical Oncology 2016 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2016.67.4887 ;PMID: 28056202

Full text available

11
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype
Material Type:
Article
Add to My Research

Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype

Journal of clinical oncology, 2017-04, Vol.35 (10), p.1049-1060 [Peer Reviewed Journal]

2017 by American Society of Clinical Oncology 2017 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2015.63.1010 ;PMID: 28135148

Full text available

12
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
Material Type:
Article
Add to My Research

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial

The lancet oncology, 2014-06, Vol.15 (7), p.747-756 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 2014 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(14)70160-3 ;PMID: 24794243 ;CODEN: LANCAO

Full text available

13
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
Material Type:
Article
Add to My Research

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

JNCI : Journal of the National Cancer Institute, 2011-11, Vol.103 (22), p.1656-1664 [Peer Reviewed Journal]

The Author 2011. Published by Oxford University Press. 2011 ;Copyright Oxford Publishing Limited(England) Nov 16, 2011 ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djr393 ;PMID: 21960707 ;CODEN: JNCIEQ

Full text available

14
Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy
Material Type:
Article
Add to My Research

Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy

Journal of clinical oncology, 2013-08, Vol.31 (22), p.2783-2790 [Peer Reviewed Journal]

2014 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2012.46.1558 ;PMID: 23816962

Full text available

15
Relationships between Breast Feeding and Breast Cancer Subtypes: Lessons Learned from Studies in Humans and in Mice
Material Type:
Article
Add to My Research

Relationships between Breast Feeding and Breast Cancer Subtypes: Lessons Learned from Studies in Humans and in Mice

Cancer research (Chicago, Ill.), 2020-11, Vol.80 (22), p.4871-4877 [Peer Reviewed Journal]

2020 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.CAN-20-0077 ;PMID: 32816853

Full text available

16
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Material Type:
Article
Add to My Research

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Journal of clinical oncology, 2016-04, Vol.34 (10), p.1134-1150 [Peer Reviewed Journal]

2016 by American Society of Clinical Oncology. ;2016 by American Society of Clinical Oncology 2016 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2015.65.2289 ;PMID: 26858339

Full text available

17
Prediction of breast cancer risk based on profiling with common genetic variants
Material Type:
Article
Add to My Research

Prediction of breast cancer risk based on profiling with common genetic variants

JNCI : Journal of the National Cancer Institute, 2015-05, Vol.107 (5), p.1 [Peer Reviewed Journal]

The Author 2015. Published by Oxford University Press. ;Copyright Oxford Publishing Limited(England) May 2015 ;The Author 2015. Published by Oxford University Press. 2015 ;ISSN: 0027-8874 ;ISSN: 1460-2105 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djv036 ;PMID: 25855707 ;CODEN: JNCIEQ

Full text available

18
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
Material Type:
Article
Add to My Research

11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

The Lancet (British edition), 2017-03, Vol.389 (10075), p.1195-1205 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 25, 2017 ;2017. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)32616-2 ;PMID: 28215665

Full text available

19
Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial
Material Type:
Article
Add to My Research

Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial

Journal of clinical oncology, 2016-04, Vol.34 (10), p.1034-1042 [Peer Reviewed Journal]

2015 by American Society of Clinical Oncology. ;2015 by American Society of Clinical Oncology 2015 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2015.62.1797 ;PMID: 26598744

Full text available

20
West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment
Material Type:
Article
Add to My Research

West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment

Journal of clinical oncology, 2016-07, Vol.34 (20), p.2341-2349 [Peer Reviewed Journal]

2016 by American Society of Clinical Oncology. ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2015.63.5383 ;PMID: 26926676

Full text available

Results 1 - 20 of 3,890  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (3,670)

Refine My Results

Creation Date 

From To
  1. Before 1994  (487)
  2. 1994 To 2000  (980)
  3. 2001 To 2007  (737)
  4. 2008 To 2015  (1,297)
  5. After 2015  (390)
  6. More options open sub menu

Language 

  1. English  (3,833)
  2. Japanese  (628)
  3. Spanish  (25)
  4. Portuguese  (21)
  5. French  (14)
  6. Hungarian  (7)
  7. Polish  (4)
  8. Russian  (3)
  9. Czech  (3)
  10. German  (2)
  11. Serbian  (2)
  12. Croatian  (2)
  13. Italian  (1)
  14. Norwegian  (1)
  15. More options open sub menu

Searching Remote Databases, Please Wait